AnalystsEric JosephEric Joseph's Stock Forecasts
AnalystsEric Joseph
Analyst Ranking
Bottom 11%
#4958 out of 5510 analysts
Average Return
-0.84%
Win Rate
43%43 out of 101
Risk vs Reward
Poor
Good
Eric Joseph's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Revolution Medicines IncRVMD | +382.50% | $42.51 | $205.11 | 2025-09-25 - 2026-09-14 | Strong Buy |
Revolution Medicines IncRVMD | +176.50% | $21.49 | $59.42 | 2023-11-07 - 2024-11-06 | Strong Buy |
Tg Therapeutics IncTGTX | +173.91% | $13.99 | $38.32 | 2024-04-18 - 2025-04-17 | Strong Buy |
Kymera Therapeutics IncKYMR | +161.42% | $32.17 | $84.10 | 2025-05-12 - 2026-05-11 | Strong Buy |
Tg Therapeutics IncTGTX | +147.63% | $10.12 | $25.06 | 2023-11-01 - 2024-10-31 | Strong Buy |
Eric Joseph Analyst Color
Get additional color on Eric Joseph's coverage of popular stocks
Eric Joseph's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals IncARWR | 1 | Strong Buy | $108.00 | +33.88% | Initiates Coverage On | 7 days ago |
Alnylam Pharmaceuticals IncALNY | 2 | Strong Buy | $340.00 | +36.01% | Maintains | a month ago |
Bridgebio Pharma IncBBIO | 2 | Hold | $93.00 | +28.49% | Maintains | 2 months ago |
Biomarin Pharmaceutical IncBMRN | 2 | Strong Buy | $76.00 | +14.44% | Maintains | 2 months ago |
Ionis Pharmaceuticals IncIONS | 2 | Strong Buy | $100.00 | +94.40% | Maintains | 2 months ago |
Ascendis Pharma AASND | 1 | Strong Buy | $355.00 | +34.00% | Initiates Coverage On | 4 months ago |
Cytokinetics IncCYTK | 1 | Strong Buy | $99.00 | +36.65% | Initiates Coverage On | 4 months ago |
Recursion Pharmaceuticals IncRXRX | 3 | Strong Buy | $11.00 | +222.58% | Upgrades | 9 months ago |
Tg Therapeutics IncTGTX | 5 | Strong Buy | $49.00 | -9.26% | Maintains | 10 months ago |
Beam Therapeutics IncBEAM | 4 | Strong Buy | $46.00 | +90.71% | Maintains | a year ago |
Revolution Medicines IncRVMD | 7 | Strong Buy | $71.00 | -65.38% | Maintains | a year ago |
Kymera Therapeutics IncKYMR | 4 | Strong Buy | $64.00 | N/A | Maintains | a year ago |
Rocket Pharmaceuticals IncRCKT | 4 | Hold | $7.00 | N/A | Downgrades | a year ago |
Prime Medicine IncPRME | 5 | Hold | N/A | N/A | Downgrades | a year ago |
Novavax IncNVAX | 8 | Strong Sell | $7.00 | N/A | Maintains | a year ago |
Ptc Therapeutics IncPTCT | 10 | Strong Buy | $67.00 | N/A | Maintains | a year ago |
Opko Health IncOPK | 3 | Hold | N/A | N/A | Initiates Coverage On | a year ago |
Bluebird Bio IncBLUE | 3 | Hold | N/A | N/A | Upgrades | 2 years ago |
Pliant Therapeutics IncPLRX | 4 | Hold | N/A | N/A | Downgrades | 2 years ago |
Nurix Therapeutics IncNRIX | 7 | Strong Buy | $30.00 | N/A | Maintains | 2 years ago |
Igm Biosciences IncIGMS | 8 | Hold | N/A | N/A | Upgrades | 2 years ago |
Vir Biotechnology IncVIR | 5 | Hold | $14.00 | N/A | Maintains | 2 years ago |
Septerna IncSEPN | 1 | Strong Buy | $38.00 | N/A | Initiates Coverage On | 2 years ago |
Camp4 Therapeutics CorpCAMP | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 2 years ago |
Wave Life Sciences IncWVE | 2 | Strong Buy | $17.00 | N/A | Maintains | 2 years ago |
Relay Therapeutics IncRLAY | 5 | Strong Buy | $21.00 | N/A | Maintains | 2 years ago |
Enanta Pharmaceuticals IncENTA | 4 | Strong Sell | $10.00 | N/A | Maintains | 2 years ago |
Hillevax IncHLVX | 4 | Hold | N/A | N/A | Downgrades | 2 years ago |
C4 Therapeutics IncCCCC | 4 | Hold | $6.00 | N/A | Upgrades | 3 years ago |
Livent CorpLTHM | 2 | Hold | $15.00 | N/A | Maintains | 3 years ago |
Monte Rosa Therapeutics IncGLUE | 2 | Strong Buy | $11.00 | N/A | Maintains | 3 years ago |
Akero Therapeutics IncAKRO | 2 | Strong Buy | $41.00 | N/A | Maintains | 3 years ago |
Lyell Immunopharma IncLYEL | 1 | Hold | $100.00 | N/A | Downgrades | 3 years ago |
Century Therapeutics IncIPSC | 2 | Hold | $5.00 | N/A | Downgrades | 3 years ago |
Atea Pharmaceuticals IncAVIR | 5 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Terns Pharmaceuticals IncTERN | 6 | Hold | $11.00 | N/A | Maintains | 3 years ago |
Mirati Therapeutics IncMRTX | 1 | Hold | $65.00 | N/A | Downgrades | 4 years ago |
Surrozen IncSRZN | 2 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Karyopharm Therapeutics IncKPTI | 2 | Hold | $120.00 | N/A | Upgrades | 5 years ago |
Aligos Therapeutics IncALGS | 2 | Hold | $300.00 | N/A | Downgrades | 5 years ago |
Omeros CorpOMER | 2 | Strong Sell | N/A | N/A | Downgrades | 5 years ago |
Freeline Therapeutics Holdings PLCFRLN | 2 | Hold | $120.00 | N/A | Downgrades | 5 years ago |
Verve Therapeutics IncVERV | 1 | Hold | $50.00 | N/A | Initiates Coverage On | 5 years ago |
Achilles Therapeutics PLCACHL | 1 | Strong Sell | $11.00 | N/A | Initiates Coverage On | 5 years ago |
Acceleron Pharma IncXLRN | 1 | Strong Buy | $153.00 | N/A | Maintains | 6 years ago |
Autolus Therapeutics PLCAUTL | 2 | Hold | $9.00 | N/A | Downgrades | 6 years ago |
Akebia Therapeutics IncAKBA | 1 | Strong Sell | N/A | N/A | Downgrades | 6 years ago |
Urovant Sciences LtdUROV | 2 | Hold | $16.00 | N/A | Downgrades | 6 years ago |
Five Prime Therapeutics IncFPRX | 2 | Hold | $14.00 | N/A | Upgrades | 6 years ago |
Obseva SaOBSVF | 1 | Hold | $5.00 | N/A | Downgrades | 6 years ago |
Black Diamond Therapeutics IncBDTX | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 7 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Strong Buy | $30.00 | N/A | Upgrades | 7 years ago |
Ironwood Pharmaceuticals IncIRWD | 2 | Hold | $13.00 | N/A | Upgrades | 8 years ago |
Sangamo Therapeutics IncSGMO | 2 | Hold | $11.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.